Michael Comilla - Abbott Laboratories Vice Relations

Abbott Laboratories Management Efficiency

The company has Return on Asset of 0.0649 % which means that on every $100 spent on assets, it made $0.0649 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1484 %, implying that it generated $0.1484 on every 100 dollars invested. Abbott Laboratories' management efficiency ratios could be used to measure how well Abbott Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abbott Laboratories' Return On Tangible Assets are comparatively stable compared to the past year. Return On Assets is likely to gain to 0.12 in 2024, whereas Return On Capital Employed is likely to drop 0.10 in 2024. At this time, Abbott Laboratories' Non Current Liabilities Other is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 44.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 8.3 B in 2024.

Similar Executives

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people. Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 and employs 114,000 people. Abbott Laboratories is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Abbott Laboratories Leadership Team

Abbott Stock Performance Indicators

Additional Tools for Abbott Stock Analysis